Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0A55 market cap is 0. The company's latest EPS is USD -0.1512 and P/E is -271.16.
| Year End 31 December 2023 | 2021 | 2023 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.74B | 3.27B | 3B |
| Operating Income | 815.66M | 843.7M | 139.1M |
| Net Income | 452.92M | 548.7M | -10.1M |
| Year End 31 December 2023 | 2021 | 2023 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.18B | 8.86B | 8.56B |
| Total Liabilities | 4.82B | 3.92B | 3.56B |
| Total Equity | 4.36B | 4.93B | 5.01B |
| Year End 31 December 2023 | 2021 | 2023 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | 885.3M | 280.2M |
| Investing | N/A | -1.64B | -187.6M |
| Financing | N/A | 252M | -265.8M |
| Market Cap | 0 |
| Price to Earnings Ratio | -271.16 |
| Price to Sales Ratio | 0.91 |
| Price to Cash Ratio | 23.04 |
| Price to Book Ratio | 0.55 |
| Dividend Yield | - |
| Shares Outstanding | 66.82M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Quidelortho Corp |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https:///www.quidelortho.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
